Right ventricular contractility in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension

European Respiratory Journal

Volumn 31, Issue 6, 2008, Pages 1160-1166

  Overbeek, M J ^a   Lankhaar, J W ^a   Westerhof, N ^a   Voskuyl, A E ^a   Boonstra, A ^a   Bronzwaer, J G F ^a   Marques, K M J ^a   Smit, E F ^a   Dijkmans, B A C ^a   Vonk Noordegraaf, A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Myocardial contraction; Pump function graph; Right ventricular function; Right ventricular pressure; Stroke volume

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART VENTRICLE CONTRACTION; HEMODYNAMICS; HUMAN; LUNG CAPACITY; LUNG FUNCTION TEST; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SYSTEMIC SCLEROSIS; COHORT ANALYSIS; COMPARATIVE STUDY; HEART CONTRACTION; HEART RIGHT VENTRICLE FUNCTION; HEART STROKE VOLUME; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; SCLERODERMA, SYSTEMIC; STROKE VOLUME; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 49649095907     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00135407     Document Type: Article

References (35)

1. Hachulla E, Gressin V, Guillevin L, et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 2005; 52: 3792-3800.
2. Mukerjee D, St George D, Coleiro B, et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 2003; 62: 1088-1093.
3. Kawut SM, Taichman DB, Archer-Chicko CL, Palevsky HI, Kimmel SE. Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis. Chest 2003; 123: 344-350.
4. Fisher MR, Mathai SC, Champion HC, et al. Clinical differences between idiopathic and scleroderma-related pulmonary hypertension. Arthritis Rheum 2006; 54: 3043-3050.
5. Dorfmuller P, Humbert M, Perros F, et al. Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases. Hum Pathol 2007; 38: 893-902.
6. Westerhof N, Stergiopulos N, Noble MIM. Pump function graph. In: Snapshots of Hemodynamics. An Aid for Clinical Research and Graduate Education. 1st Edn. New York, Springer Science and Business Media, Inc., 2005; pp. 63-70.
7. Barst RJ, McGoon M, Torbicki A, et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43: Suppl. 12, 40S-47S.
8. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-205.
9. Mahapatra S, Nishimura RA, Sorajja P, Cha S, McGoon MD. Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hypertension. J Am Coll Cardiol 2006; 47: 799-803.
10. Chemla D, Hebert JL, Coirault C, et al. Total arterial compliance estimated by stroke volume-to-aortic pulse pressure ratio in humans. Am J Physiol 1998; 27: H500-H505.
11. van den Horn GJ, Westerhof N, Elzinga G. Optimal power generation by the left ventricle. A study in the anesthetized open thorax cat. Circ Res 1985; 56: 252-261.
12. Sunagawa K, Yamada A, Senda Y, et al. Estimation of the hydromotive source pressure from ejecting beats of the left ventricle. IEEE Trans Biomed Eng 1980; 27: 299-305.
13. Brimioulle S, Wauthy P, Ewalenko P, et al. Single-beat estimation of right ventricular end-systolic pressure-volume relationship. Am J Physiol Heart Circ Physiol 2003; 284: H1625-H1630.
14. Steen V, Medsger TA Jr. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum 2003; 48: 516-522.
15. Stupi AM, Steen VD, Owens GR, Barnes EL, Rodnan GP, Medsger TA Jr. Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthritis Rheum 1986; 29: 515-524.
16. Elzinga G, Westerhof N. The effect of an increase in inotropic state and end-diastolic volume on the pumping ability of the feline left heart. Circ Res 1978; 42: 620-628.
17. Elzinga G, Westerhof N. How to quantify pump function of the heart. The value of variables derived from measurements on isolated muscle. Circ Res 1979; 44: 303-308.
18. Suga H, Sagawa K, Shoukas AA. Load independence of the instantaneous pressure-volume ratio of the canine left ventricle and effects of epinephrine and heart rate on the ratio. Circ Res 1973; 32: 314-322.
19. Baan J, van der Velde ET, de Bruin HG, et al. Continuous measurement of left ventricular volume in animals and humans by conductance catheter. Circulation 1984; 70: 812-823.
20. Kuehne T, Yilmaz S, Steendijk P, et al. Magnetic resonance imaging analysis of right ventricular pressure-volume loops: in vivo validation and clinical application in patients with pulmonary hypertension. Circulation 2004; 110: 2010-2016.
21. Follansbee WP, Miller TR, Curtiss EI, et al. A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma). J Rheumatol 1990; 17: 656-662.
22. Owens GR, Follansbee WP. Cardiopulmonary manifestations of systemic sclerosis. Chest 1987; 91: 118-127.
23. Fernandes F, Ramires FJ, Arteaga E, Ianni BM, Bonfa ES, Mady C. Cardiac remodeling in patients with systemic sclerosis with no signs or symptoms of heart failure: an endomyocardial biopsy study. J Card Fail 2003; 9: 311-317.
24. Westerhof N, Boer C, Lamberts RR, Sipkema P. Cross-talk between cardiac muscle and coronary vasculature. Physiol Rev 2006; 86: 1263-1308.
25. Lamberts RR, Willemsen MJ, Perez NG, Sipkema P, Westerhof N. Acute and specific collagen type I degradation increases diastolic and developed tension in perfused rat papillary muscle. Am J Physiol Heart Circ Physiol 2004; 286: H889-H894.
26. Brower GL, Gardner JD, Forman MF, et al. The relationship between myocardial extracellular matrix remodeling and ventricular function. Eur J Cardiothorac Surg 2006; 30: 604-610.
27. Chanoki M, Ishii M, Kobayashi H, et al. Increased expression of lysyl oxidase in skin with scleroderma. Br J Dermatol 1995; 133: 710-715.
28. Brinckmann J, Neess CM, Gaber Y, et al. Different pattern of collagen cross-links in two sclerotic skin diseases: lipodermatosclerosis and circumscribed scleroderma. J Invest Dermatol 2001; 117: 269-273.
29. Bulkley BH, Ridolfi RL, Salyer WR, Hutchins GM. Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction. Circulation 1976; 53: 483-490.
30. Kahan A, Nitenberg A, Foult JM, et al. Decreased coronary reserve in primary scleroderma myocardial disease. Arthritis Rheum 1985; 28: 637-646.
31. Overbeek MJ, Gan CT, Westerhof N, et al. Cardiac contractility is impaired in systemic sclerosis-associated pulmonary hypertension compared to idiopathic pulmonary hypertension. Am J Respir Crit Care Med 2007; 175: 1002.
32. Meune C, Allanore Y, Devaux JY, et al. High prevalence of right ventricular systolic dysfunction in early systemic sclerosis. J Rheumatol 2004; 31: 1941-1945.
33. Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med 1987; 107: 216-223.
34. Fleg JL, O'Connor F, Gerstenblith G, et al. Impact of age on the cardiovascular response to dynamic upright exercise in healthy men and women. J Appl Physiol 1995; 78: 890-900.
35. Klein AL, Leung DY, Murray RD, Urban LH, Bailey KR, Tajik AJ. Effects of age and physiologic variables on right ventricular filling dynamics in normal subjects. Am J Cardiol 1999; 84: 440-448.